Intendis GmbH Enters Market as New Dermatology Specialist

Intendis GmbH has started operations as a new, fully integrated pharmaceutical company, dedicated to the development and marketing of systemic and topical treatments for skin disorders. Intendis is a 100 percent owned subsidiary of Schering AG, Germany. At a press conference in Berlin, Intendis management introduced the new company and its growth prospects. It is pursuing a strategy to invest in the marketing of the group's well-established dermatology brands in the areas of eczema, psoriasis, acne, rosacea, and fungal infections to broaden their global reach.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=18923820&full=1)